logo

SYNCOMF vs WOCKPHARMA: Stock Comparison

SYNCOM FORMU (I) vs WOCKHARDTUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. SYNCOM FORMU (I) shows a lower P/E, a higher ROE and a higher dividend yield, while WOCKHARDT shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SYNCOMF leads 9; WOCKPHARMA leads 2 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SYNCOMFWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹2,053 Cr
₹30,126 Cr
P/E RatioSYNCOMF has the lower reading
24x ✓
73.66x
P/B RatioSYNCOMF has the lower reading
4.95x ✓
6.1x
EPSWOCKPHARMA has the higher reading
₹0.26
₹6.52 ✓
Book ValueContext only
₹4.41
₹325
Dividend YieldSYNCOMF has the higher reading
0.45% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,126 Cr vs ₹2,053 Cr
P/E Ratio
SYNCOMF has a lower P/E
24x vs 73.66x
P/B Ratio
SYNCOMF has a lower P/B
4.95x vs 6.1x
EPS
WOCKPHARMA has higher earnings per share
₹6.52 vs ₹0.26
Dividend Yield
SYNCOMF has a higher dividend yield
0.45% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs -9%
EPS Growth (TTM YoY)
SYNCOMF has faster EPS growth
68.8% vs 0%
ROE
SYNCOMF has a higher ROE
18.42% vs 3.77%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSYNCOMFWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSYNCOMFWOCKPHARMA
Live Price₹22.08₹1,855.5
Day Change0.05%-1.16%
Volume2.26 Cr4.57 L
52-Week High₹27.49₹2,422.3
52-Week Low₹10.21₹1,086.7
Distance from 52W High-19.68%-23.4%

Valuation

MetricSYNCOMFWOCKPHARMA
Market Cap₹2,053 Cr₹30,126 Cr
P/E Ratio24x73.66x
P/B Ratio4.95x6.1x
EPS₹0.26₹6.52
Book Value₹4.41₹325
Dividend Yield0.45%0%

Growth

MetricSYNCOMFWOCKPHARMA
Revenue Growth (TTM YoY)-9%26%
EPS Growth (TTM YoY)68.8%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricSYNCOMFWOCKPHARMA
ROE18.42%3.77%
ROCE18.57%5.44%
Net Margin15.63%3.3%
Operating Margin20.91%13.37%
Debt to Equity0x0.4x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricSYNCOMFWOCKPHARMA
Promoter Holding50.57%49.08%
FII Holding2.22%▲ 1.87 pp7.22%▲ 0.13 pp
DII Holding0%9.24%▼ 1.72 pp
Public Holding47.2%▼ 1.88 pp34.44%▲ 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SYNCOM FORMU (I) and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.